Fundraising Fox

Envisagenics

New York, US · 3 known investors

envisagenics.com ↗

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases. The company combines RNA biology expertise with machine learning to advance precision medicines.

AI & Machine LearningBiotechMedical Devicesin /envisagenics

Founders & leadership

MP
Maria Pineda, PhDCEO & Co-founder
MA
Martin Akerman, PhDCEO & Co-founder

Investors · 3

Dynamk CapitalNew York
Madrona Venture GroupSeattle
Dolby Family VenturesreportedSan Francisco

In the news